ESMO Recommendations for the Application of Hematopoietic Growth Factors

Ann Oncol. 2005;16 Suppl 1:i80-2. doi: 10.1093/annonc/mdi813.

Publication types

  • Guideline
  • Practice Guideline

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Fever / chemically induced
  • Fever / drug therapy*
  • Filgrastim
  • Granulocyte Colony-Stimulating Factor / therapeutic use*
  • Hematopoietic Stem Cell Mobilization
  • Humans
  • Neutropenia / chemically induced*
  • Neutropenia / drug therapy*
  • Polyethylene Glycols
  • Recombinant Proteins
  • Risk Factors
  • Stem Cell Transplantation

Substances

  • Recombinant Proteins
  • Granulocyte Colony-Stimulating Factor
  • pegfilgrastim
  • Polyethylene Glycols
  • Filgrastim